%0 Journal Article
%A Bohlken, Jens
%A Kostev, Karel
%A Michalowsky, Bernhard
%T Alzheimer-Demenz und Antidementiva-Verordnungen 2010–2021 in 357 Hausarzt- und 71 Facharztpraxen  -  Alzheimer's Dementia and Anti-Dementia Medication Prescriptions 2010-2021 in 357 GP Practices and 71 Specialist Practices
%J Psychiatrische Praxis
%V 52
%N 1
%@ 0303-4259
%C Stuttgart
%I Thieme
%M DZNE-2025-00139
%P 44 - 47
%D 2025
%X The predicted prevalence of people with dementia (PWD) in Germany has risen to 1.8 million since 2010. In the near future, we will see the approval of antibody therapies. The study aims to demonstrate the recent anti-dementia medication prescriptions and diagnosis prevalence.Data from 357 general practitioner (GP) and 71 specialist practices (SP) (1.1 Mio. patients) were analyzed to demonstrate the prevalence of dementia diagnoses and anti-dementia drug prescriptions between 2010 and 2021.The diagnosis prevalence of PWD (Alzheimer's dementia) remained relatively constant in GP practices at 1.0-1.3
%K Alzheimer Disease: drug therapy
%K Alzheimer Disease: epidemiology
%K Alzheimer Disease: diagnosis
%K Humans
%K Germany
%K Aged
%K General Practice: statistics & numerical data
%K Male
%K Female
%K Aged, 80 and over
%K Practice Patterns, Physicians': statistics & numerical data
%K Forecasting
%K Drug Prescriptions: statistics & numerical data
%K Cross-Sectional Studies
%K Dementia: drug therapy
%K Dementia: epidemiology
%K Nootropic Agents: therapeutic use
%K Nootropic Agents (NLM Chemicals)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:39384316
%R 10.1055/a-2370-1933
%U https://pub.dzne.de/record/275906